Loading...

ACI: Digital Integration And Customer Engagement Will Drive Outperformance Beyond 2025

Published
12 Jan 25
Updated
01 Jun 26
Views
385
01 Jun
US$16.36
AnalystConsensusTarget's Fair Value
US$20.94
21.9% undervalued intrinsic discount
Loading
1Y
-23.7%
7D
4.8%

Author's Valuation

US$20.9421.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 01 Jun 26

Fair value Decreased 0.30%

ACI: Cost Discipline And Buybacks Will Support Earnings Resilience Despite Sector Caution

Albertsons Companies' analyst price target edges slightly lower to about $20.94 from $21.00, as analysts factor in updated assumptions for discount rates, revenue growth, profit margins, and future P/E multiples, which are reflected in recent target cuts across several firms.

Analyst Commentary

Recent Street research on Albertsons Companies has leaned toward more cautious pricing, with several firms trimming their targets and one prior increase earlier in the year. Here is how the latest commentary breaks down for investors trying to make sense of the shifting targets.

Bullish Takeaways

  • Some bullish analysts had previously moved targets up to around US$20, which signals a view that the stock could justify a mid-teens or higher P/E multiple if execution on profitability and cash flow holds steady.
  • The use of an "In Line" rating alongside higher past targets suggests a view that Albertsons can track reasonably close to sector peers on growth and margin delivery, even without a strong outperformance call.
  • Incremental target changes of around US$1 in prior upward revisions indicate that bullish analysts are treating the stock as a measured opportunity rather than a high-risk, high-reward bet, which may appeal to more conservative investors.

Bearish Takeaways

  • Bearish analysts have trimmed price targets by roughly US$1 to US$4, which points to reduced conviction around what investors might be willing to pay for the stock on earnings or cash flow multiples.
  • The clustering of recent cuts implies concern around execution risk, whether tied to revenue growth, profit margins, or the timing and level of any potential re-rating in the P/E multiple.
  • JPMorgan removing the stock from its Analyst Focus List signals that some large institutions are less comfortable highlighting Albertsons as a priority idea, which can influence how much attention the stock receives from bigger pools of capital.
  • Across the bearish camp, modest step-downs in targets rather than dramatic resets suggest that analysts are more cautious on valuation support than on the basic business model, but still see less upside than before under their current assumptions.

What's in the News

  • Albertsons launched a patent-pending Intelligent Quality Control tool that uses Google Cloud’s Gemini Enterprise, including Vision AI and Gemini models, to support produce inspections at distribution centers. Early use is focused on strawberries and red and green grapes, with plans to expand across berries and more fresh products. (Source: company announcement)
  • Baron & Budd announced a finalized US$774 million nationwide settlement with Albertsons to resolve litigation related to the company’s role in the opioid epidemic. Funds are set to be distributed to states, counties, municipalities, and Native American tribes as part of a broader national recovery effort of more than US$60b. (Source: Baron & Budd)
  • Albertsons Media Collective introduced onsite incrementality measurement to help advertisers assess the causal impact of onsite display media on sales. The capability uses test and control frameworks and reporting metrics such as incremental return on ad spend and new-to-brand buyers. (Source: Albertsons Media Collective)
  • Albertsons provided earnings guidance for fiscal 2026, indicating expected identical sales growth in a range of 0.0% to 1.0%. (Source: company guidance)
  • The company reported several capital return and balance sheet actions for fiscal 2026, including an increased quarterly dividend of US$0.17 per share (US$0.68 annualized) and a higher share repurchase authorization from US$900 million to US$2.0b. (Source: company announcement)

Valuation Changes

  • Fair Value: trimmed slightly from $21.00 to about $20.94 per share.
  • Discount Rate: risen slightly from 10.05% to about 10.08%, which implies a marginally higher required return in the model.
  • Revenue Growth: reduced in the model from roughly 82.67% to about 72.69%, indicating a lower assumed growth rate.
  • Profit Margin: increased in the forecast from about 114.57% to roughly 119.49%, pointing to a higher expected level of profitability in the assumptions.
  • Future P/E: moved down from about 11.38x to roughly 10.92x, which reflects a modestly lower valuation multiple applied to future earnings.
10 viewsusers have viewed this narrative update

Key Takeaways

  • Growth in digital channels, health offerings, and loyalty programs is enhancing customer engagement, retention, and overall sales momentum.
  • Technology upgrades, private label expansion, and omnichannel integration are strengthening margins, operational efficiency, and competitive positioning.
  • Margin and earnings growth are pressured by lagging e-commerce, rising labor costs, pharmacy mix headwinds, stiff competition, and slow realization of cost-saving initiatives.

Catalysts

About Albertsons Companies
    Through its subsidiaries, operates in the food and drug retail industry in the United States.
What are the underlying business or industry changes driving this perspective?
  • Accelerating growth in digital channels-including a 25% surge in e-commerce sales and a robust loyalty program-strongly positions Albertsons to capitalize on rising consumer demand for convenience and online grocery ordering, supporting higher future revenue and customer retention.
  • Expansion and integration of pharmacy and health offerings (20% YoY growth), with enhanced digital cross-shopping, is increasing customer engagement, driving more frequent visits, and boosting overall basket size, directly benefiting top-line sales and increasing customer lifetime value.
  • Modernization through technology investments-such as automation, AI-driven inventory/pricing, and centralized buying-are streamlining operations, reducing labor and supply chain costs, and positioning the company for long-term margin expansion and improved net earnings.
  • Increasing penetration of private label and own brands (now at 25.7% of sales with a push to reach 30%+), along with targeted value investments, are driving higher-margin sales, deepening brand loyalty, and contributing to gross margin stabilization over time.
  • Leveraging omnichannel capabilities and integrated digital experiences is enabling Albertsons to better compete for market share amidst urbanization and evolving health and wellness trends, which supports sustained same-store sales growth and overall top-line momentum.
Albertsons Companies Earnings and Revenue Growth

Albertsons Companies Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Albertsons Companies's revenue will remain fairly flat over the next 3 years.
  • Analysts assume that profit margins will increase from 0.3% today to 1.2% in 3 years time.
  • Analysts expect earnings to reach $1.0 billion (and earnings per share of $2.42) by about June 2029, up from $217.4 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $1.2 billion in earnings, and the most bearish expecting $903.5 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 10.9x on those 2029 earnings, down from 35.5x today. This future PE is lower than the current PE for the US Consumer Retailing industry at 18.5x.
  • Analysts expect the number of shares outstanding to decline by 7.0% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 10.08%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Albertsons' e-commerce business, though growing at 25% year-over-year, still lags industry peers in penetration, and reaching breakeven profitability remains a challenge; a persistent gap or inability to scale digital efficiently could result in continued pressure on net margins and limit overall earnings growth.
  • Rising labor costs and ongoing union contract negotiations, as evidenced by 120,000 associates potentially affected in FY25 and a focus on improved wages and benefits, pose long-term risks of margin compression and higher SG&A expense, which could negatively impact net income.
  • The grocery industry's highly competitive landscape-marked by sustained price investments, heavy promotional activity, and mounting pressure from mass, club, and discount value players (as well as non-traditional entrants like Amazon and Dollar General)-threatens to erode Albertsons' pricing power and market share, squeezing revenue growth and profitability.
  • Growth is increasingly driven by the pharmacy segment (notably from high-priced GLP-1 drugs) rather than core grocery sales, but pharmacy often carries lower profitability and creates sustained mix headwinds for gross margin; over-reliance on this trend exposes future revenue and margin risk if pharmacy growth normalizes or reimbursement rates tighten.
  • Despite technology and productivity investments, the company's near-term gross margin is under pressure as savings from supply chain efficiencies and national buying only gradually materialize, while aggressive investment in price and customer value is required to support unit growth; this mismatch could delay or dampen EBITDA and earnings growth in the face of inflation and secular consumer shifts towards value and healthier specialty foods.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $20.94 for Albertsons Companies based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $26.0, and the most bearish reporting a price target of just $14.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $85.0 billion, earnings will come to $1.0 billion, and it would be trading on a PE ratio of 10.9x, assuming you use a discount rate of 10.1%.
  • Given the current share price of $15.61, the analyst price target of $20.94 is 25.4% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Albertsons Companies?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$14.75
FV
11.0% overvalued intrinsic discount
0.57%
Revenue growth p.a.
17
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$29.74
FV
45.0% undervalued intrinsic discount
2.79%
Revenue growth p.a.
14
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative